Donati D, Degiannis D, Homer L, Raska K, Raskova J
Department of Pathology, UMDNJ-Robert Wood Johnson Medical School, Piscataway.
ASAIO Trans. 1991 Jul-Sep;37(3):M391-2.
Interleukin-1 (IL-1) was measured in the plasma and in mononuclear cell (MC) lysates from patients on maintenance hemodialysis (HD) using either cuprophan (CU) or polysulfone (PS) membranes. Basal plasma levels of IL-1 in HD patients were significantly higher than those of uremic patients on conservative treatment or of healthy subjects. In 10 patients on conservative treatment, plasma levels of IL-1 increased significantly after 3 and 6 months of HD. During a single HD session, plasma IL-1 fell to 21% (CU) and 22% (PS) of pre-HD levels. Hemodialysis patients had a significantly higher intracellular IL-1 content than normal controls. During HD, a further increase was seen regardless of the membrane employed. A parallel in vitro study showed that IL-1 produced during HD requires at least 24 hours to be released, and that both CU and PS are able to bind and clear IL-1.
使用铜仿膜(CU)或聚砜膜(PS)对维持性血液透析(HD)患者的血浆和单核细胞(MC)裂解物中的白细胞介素-1(IL-1)进行了测定。HD患者的基础血浆IL-1水平显著高于接受保守治疗的尿毒症患者或健康受试者。在10例接受保守治疗的患者中,HD治疗3个月和6个月后血浆IL-1水平显著升高。在单次HD治疗期间,血浆IL-1降至HD前水平的21%(CU)和22%(PS)。血液透析患者的细胞内IL-1含量显著高于正常对照组。在HD期间,无论使用何种膜,均可见进一步升高。一项平行的体外研究表明,HD期间产生的IL-1至少需要24小时才能释放,并且CU和PS均能够结合并清除IL-1。